Teddi Mellencamp shares reflections on the commentary on the breakdown of fans in the middle of misfortune cancer

Teddi Mellencamp shares reflections on the commentary on the breakdown of fans in the middle of misfortune cancer

Teddi Mellencamp asks his fans to be aware of their pitiful comments on his diagnosis of stadium cancer four.

The star of reality, 43, transmitted his concerns Thursday via Instagram Stories, sharing a screenshot of a comment that caught his attention.

“This kind of comments makes me really sad”, Real Housewives of Beverly Hills The alum wrote on a screenshot which she shared from the remark that her fan had made to a previous story.

This overwhelming remark said: “It’s so heartbreaking. As a rule, stadium four cancer is in terminal phase, in particular with metastases. Praying so that Teddi healed and is an aberrant value.”

Stade 4 cancer has the highest mortality rates compared to those captured at an early stage, but it is not always terminal.

Reflecting further on the fan’s comment, MellenoCamp said that she wanted to stay full of hope despite the chances.

“Of course, I know the chances but I really believe with all my heart, I will beat this and look at my graduate children,” she said.

The personal coach, who also manages a podcast entitled Two t in a podThen added humorously that she would be there for years so that she could “let off steam on the pod and make everyone get angry with me. Bore my brothers and sisters by reminding everyone that I am the favorite. etc.”

Teddi shares three children – Daughters Slate, 12, and Dove, five years old, and a Cruz son, 10, with his ex -husband Edwin Arribneave, it was reported that the pair still lived together to help take care of their children while it undergoes cancer treatments.

Teddi also shared progress in her case with a video of herself ringing a bell in the hospital – a tradition once a patient has finished the treatment.

“Ringing the bell can signify a major treatment phase – it was my last day of radiation 5 Other laps of immunotherapy.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top